CT and PET imaging in non-small cell lung cancer

Critical Reviews in Oncology/Hematology

Volumn 58, Issue 1, 2006, Pages 15-30

  Knoepp, Ursula W ^a   Ravenel, James G ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Computed tomography (CT); Lung cancer; Positron emission tomography (PET)

Indexed keywords

CHOLINE; FLUORODEOXYGLUCOSE F 18; METHIONINE; THYMIDINE;

ADRENAL METASTASIS; BONE METASTASIS; BRAIN METASTASIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; LIVER METASTASIS; LUNG NON SMALL CELL CANCER; POSITRON EMISSION TOMOGRAPHY; REVIEW;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33644934363     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2005.09.001     Document Type: Review

References (125)

1. S.J. Swensen, M.D. Silverstein, D.M. Ilstrup, C.D. Schleck, and E.S. Edell The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules Arch Intern Med 157 8 1997 849 855
2. C.I. Henschke, D.F. Yankelevitz, and D.P. Naidich CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans Radiology 231 1 2004 164 168 (E-publication February 27, 2004)
3. S.G. Jennings, H.T. Winer-Muram, R.D. Tarver, and M.O. Farber Lung tumor growth: assessment with CT - comparison of diameter and cross-sectional area with volume measurements Radiology 231 3 2004 866 871
4. D.F. Yankelevitz, A.P. Reeves, W.J. Kostis, B. Zhao, and C.I. Henschke Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation Radiology 217 1 2000 251 256
5. C.I. Henschke, D.F. Yankelevitz, R. Mirtcheva, G. McGuinness, D. McCauley, and O.S. Miettinen CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules AJR Am J Roentgenol 178 5 2002 1053 1057
6. E.M. Rohren, T.G. Turkington, and R.E. Coleman Clinical applications of PET in oncology Radiology 231 2 2004 305 332 Epub 2004 Mar 24
7. V.J. Lowe, J.M. Hoffman, D.M. DeLong, E.F. Patz, and R.E. Coleman Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities J Nucl Med 35 11 1994 1771 1776
8. M.K. Gould, C.C. Maclean, W.G. Kuschner, C.E. Rydzak, and D.K. Owens Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis JAMA 285 7 2001 914 924
9. D.R. Croft, J. Trapp, and K. Kernstine FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence Lung Cancer 36 3 2002 297 301
10. J. Erasmus, H. McAdams, E. Patz Jr., R. Coleman, V. Ahuja, and P. Goodman Evaluation of primary pulmonary carcinoid tumors using FDG PET AJR 170 1998 1369 1373
11. J. Erasmus, H. McAdams, and E. Patz Jr. Non-small cell lung cancer: FDG-PET imaging J Thorac Imag 14 1999 247 256
12. E.M. Marom, S. Sarvis, J.E. Herndon 2nd, and E.F. Patz Jr. T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET Radiology 223 2 2002 453 459
13. J.J. Erasmus, H.P. McAdams, E.F. Patz Jr., P.C. Goodman, and R.E. Coleman Thoracic FDG PET: state of the art Radiographics 18 1 1998 5 20
14. S.A. Nehmeh, Y.E. Erdi, and C.C. Ling Effect of respiratory gating on reducing lung motion artifacts in PET imaging of lung cancer Med Phys 29 3 2002 366 371
15. S.A. Nehmeh, Y.E. Erdi, and C.C. Ling Effect of respiratory gating on quantifying PET images of lung cancer J Nucl Med 43 7 2002 876 881
16. Y.E. Erdi, S.A. Nehmeh, and T. Pan The CT motion quantitation of lung lesions and its impact on PET-measured SUVs J Nucl Med 45 8 2004 1287 1292
17. T. Yasukawa, K. Yoshikawa, and H. Aoyagi Usefulness of PET with 11C-methionine for the detection of hilar and mediastinal lymph node metastasis in lung cancer J Nucl Med 41 2000 283 290
18. O.S. Nettelbladt, A.E. Sundin, and S.O. Valind Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum J Nucl Med 39 4 1998 640 647
19. T. Hara, K. Inagaki, N. Kosaka, and T. Morita Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET J Nucl Med 41 9 2000 1507 1513
20. N. Khan, N. Oriuchi, and H. Zhang A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer Nucl Med Commun 24 4 2003 359 366
21. A.F. Shields, J.R. Grierson, and B.M. Dohmen Imaging proliferation in vivo with [F-18]FLT and positron emission tomography Nat Med 4 11 1998 1334 1336
22. A.K. Buck, G. Halter, and H. Schirrmeister Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG J Nucl Med 44 9 2003 1426 1431
23. H. Dittmann, B.M. Dohmen, and F. Paulsen [18F]FLT PET for diagnosis and staging of thoracic tumours Eur J Nucl Med Mol Imaging 30 10 2003 1407 1412 E-publication July 26, 2003
24. D.C. Cobben, P.H. Elsinga, and H.J. Hoekstra Is 18F-3′-fluoro- 3′-deoxy-l-thymidine useful for the staging and restaging of non-small cell lung cancer? J Nucl Med 45 10 2004 1677 1682
25. C. Mountain Revisions in the international system for staging lung cancer Chest 111 1997 1710 1717
26. P.N. Cascade, B.H. Gross, and E.A. Kazerooni Variability in the detection of enlarged mediastinal lymph nodes in staging lung cancer: a comparison of contrast-enhanced and unenhanced CT AJR Am J Roentgenol 170 4 1998 927 931
27. L.B. Haramati, A.M. Cartagena, and J.H. Austin CT evaluation of mediastinal lymphadenopathy: noncontrast 5 mm vs postcontrast 10 mm sections J Comput Assist Tomogr 19 3 1995 375 378
28. E.J. Patz, J. Erasmus, and H. McAdams Lung cancer staging and management: comparison of contrast-enhanced and nonenhanced helical CT of the thorax Radiology 212 1999 56 60
29. J.L. Pearlberg, M.A. Sandler, G.H. Beute, J.W. Lewis Jr., and B.L. Madrazo Limitations of CT in evaluation of neoplasms involving chest wall J Comput Assist Tomogr 11 2 1987 290 293
30. D.R. Pennes, G.M. Glazer, K.J. Wimbish, B.H. Gross, R.W. Long, and M.B. Orringer Chest wall invasion by lung cancer: limitations of CT evaluation AJR Am J Roentgenol 144 3 1985 507 511
31. H.S. Glazer, J. Duncan-Meyer, D.J. Aronberg, J.F. Moran, R.G. Levitt, and S.S. Sagel Pleural and chest wall invasion in bronchogenic carcinoma: CT evaluation Radiology 157 1 1985 191 194
32. Y. Ohno, K. Sugimura, and H. Hatabu MR imaging of lung cancer Eur J Radiol 44 3 2002 172 181
33. S. Shiotani, K. Sugimura, and M. Sugihara Diagnosis of chest wall invasion by lung cancer: useful criteria for exclusion of the possibility of chest wall invasion with MR imaging Radiat Med 20 2000 697 713
34. J.J. Erasmus, H.P. McAdams, S.E. Rossi, P.C. Goodman, R.E. Coleman, and E.F. Patz FDG PET of pleural effusions in patients with non-small cell lung cancer AJR Am J Roentgenol 175 1 2000 245 249
35. N.C. Gupta, J.S. Rogers, and G.M. Graeber Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion Chest 122 6 2002 1918 1924
36. G.M. Glazer, B.H. Gross, L.E. Quint, I.R. Francis, F.L. Bookstein, and M.B. Orringer Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping AJR Am J Roentgenol 144 2 1985 261 265
37. K. Suzuki, K. Nagai, J. Yoshida, M. Nishimura, K. Takahashi, and Y. Nishiwaki Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer J Thorac Cardiovasc Surg 117 3 1999 593 598
38. K. Takamochi, K. Nagai, and J. Yoshida The role of computed tomographic scanning in diagnosing mediastinal node involvement in non-small cell lung cancer J Thorac Cardiovasc Surg 119 2000 1135 1140
39. J.F. Vansteenkiste, S.G. Stroobants, and P.R. De Leyn Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients J Clin Oncol 16 1998 2142 2149
40. J.F. Vansteenkiste, S.G. Stroobants, and P.J. Dupont FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localization of regional lymph node metastases? Eur J Nucl Med 25 1998 1495 1501
41. H. Osada, K. Kojima, H. Tsukada, Y. Nakajima, K. Imamura, and J. Matsumoto Cost-effectiveness associated with the diagnosis and staging of non-small-cell lung cancer Jpn J Thorac Cardiovasc Surg 49 2001 1 10
42. M. Kamiyoshihara, O. Kawashima, S. Ishikawa, and Y. Morishita Mediastinal lymph node evaluation by computed tomographic scan in lung cancer J Cardiovasc Surg 42 2001 119 124
43. D.P. Dunagan, R. Chin, and T.W. McCain Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer Chest 119 2001 333 339
44. E.M. Marom, H.P. McAdams, and J.J. Erasmus Staging non-small cell lung cancer with whole-body PET Radiology 212 3 1999 803 809
45. R. Pieterman, J. van Putten, and J. Meuzelaar Preoperative staging of non-small cell lung cancer with positron-emission tomograp N Engl J Med 343 2000 254 261
46. S.L. Primack, K.S. Lee, P.M. Logan, R.R. Miller, and N.L. Muller Bronchogenic carcinoma: utility of CT in the evaluation of patients with suspected lesions Radiology 193 1994 795 800
47. T. Bury, P. Paulus, and A. Dowlati Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer Eur Respir J 9 1996 2560 2564
48. T. Bury, A. Dowlati, and P. Paulus Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer Eur Respir J 10 1997 2529 2534
49. A. Gdeedo, P. Van Schil, B. Corthouts, F. Van Mieghem, J. Van Meerbeeck, and E. Van Marck Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging Eur Respir J 10 1997 1547 1551
50. C.A.B. Saunders, J.E. Dussek, and M.J. O'Doherty Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer Ann Thorac Surg 67 1999 790 797
51. C. Aaby, S. Kristensen, and S. Nielsen Mediastinal staging of non-small-cell lung cancer: computed tomography and cervical mediastinoscopy ORL J Otorhinolaryngol Relat Spec 57 1995 279 285
52. G. Buccheri, A. Biggi, and D. Ferrigno Anti-CEA immunoscintigraphy and computed tomographic scanning in the preoperative evaluation of mediastinal lymph nodes in lung cancer Thorax 51 4 1996 359 363
53. iK Yoko, A. Okuyama, and K. Mori Mediastinal lymph node metastasis from lung cancer: evaluation with T1-201 SPECT-comparison with CT Radiology 192 1994 813 817
54. T. McLoud, P. Bourgouin, and R. Greenberg Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling Radiology 182 1992 319 323
55. P.C. Jolly, C.H. Hutchinson, F. Detterbeck, S.W. Guyton, B. Hofer, and R.P. Anderson Routine computed tomographic scans, selective mediastinoscopy, and other factors in evaluation of lung cancer J Thorac Cardiovasc Surg 102 1991 266 270
56. P.H. Cole, A. Roszkowski, A. Firouz-Abadi, and A. Dare Computerised tomography does not predict N2 disease in patients with lung cancer Aust NZ J Med 23 6 1993 688 691
57. E.M. Toloza, L. Harpole, and D.C. McCrory Noninvasive staging of non-small cell lung cancer: a review of the current evidence Chest 123 Suppl. 1 2003 137S 146S
58. M. Farrell, H. McAdams, J. Herndon, and E. Patz Jr. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease Radiology 215 2000 886 890
59. A. Guhlmann, M. Storck, J. Kotzerke, F. Moog, L. Sunder-Plassmann, and S.N. Reske Lymph node staging in non-small cell lung cancer: evaluation by [18F] FDG positron emission tomography (PET) Thorax 52 1997 438 441
60. D.A. Sazon, S.M. Santiago, and G.W. Soo Hoo Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer Am J Respir Crit Care Med 153 1996 417 421
61. W.J. Scott, L.S. Gobar, J.D. Terry, N.A. Dewan, and J.J. Sunderland Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography J Thorac Cardiovasc Surg 111 1996 642 648
62. R.L. Wahl, L.E. Quint, R.L. Greenough, C.R. Meyer, R.J. White, and M.B. Orringer Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation Radiology 191 1994 371 377
63. R. Chin Jr., R. Ward, and J.W. Keyes Mediastinal staging of non-small-cell lung cancer with positron emission tomography Am J Respir Crit Care Med 152 1995 2090 2096
64. H.C. Steinert, M. Hauser, and F. Allemann Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling Radiology 202 1997 441 446
65. P. Magnani, A. Carretta, and G. Rizzo FDG/PETand spiral CT image fusion for mediastinal lymph node assessment of non-small cell lung cancer patients J Cardiovasc Surg 40 1999 741 748
66. F. Liewald, S. Grosse, and M. Storck How useful is positron emission tomography for lymph node staging in non-small-cell lung cancer? Thorac Cardiovasac Surg 48 2000 93 96
67. P.F. Roberts, D.M. Follette, and D. von Haag Factors associated with false-positive staging of lung cancer by positron emission tomography Ann Thorac Surg 70 2000 1154 1160
68. M.K. Gould, W.G. Kuschner, and C.E. Rydzak Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis Ann Intern Med 139 11 2003 879 892
69. C.E. Reed, D.H. Harpole, and K.E. Posther Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer J Thorac Cardiovasc Surg 126 6 2003 1943 1951
70. G.V. Gonzalez-Stawinski, A. Lemaire, and F. Merchant A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer J Thorac Cardiovasc Surg 126 6 2003 1900 1905
71. R.J. Cerfolio, B. Ojha, A.S. Bryant, C.S. Bass, A.A. Bartalucci, and J.M. Mountz The role of FDG-PET scan in staging patients with nonsmall cell carcinoma Ann Thorac Surg 76 3 2003 861 866
72. T.P. Graeter, D. Hellwig, K. Hoffmann, D. Ukena, C.M. Kirsch, and H.J. Schafers Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy Ann Thorac Surg 75 1 2003 231 235 discussion 5-6
73. K.H. Kernstine, K.A. McLaughlin, and Y. Menda Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer? Ann Thorac Surg 73 2 2002 394 401 discussion 2
74. H. van Tinteren, O.S. Hoekstra, and E.F. Smit Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial Lancet 359 9315 2002 1388 1393
75. R.C. Viney, M.J. Boyer, and M.T. King Randomized controlled trial of the role of positron emission tomography in the management of stages I and II non-small-cell lung cancer J Clin Oncol 22 12 2004 2357 2362
76. R.F. Kelly, T. Tran, A. Holmstrom, J. Murar, and R.J. Segurola Jr. Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-d-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer Chest 125 4 2004 1413 1423
77. M.T. Truong, J.J. Erasmus, and H.A. Macapinlac Integrated positron emission tomography/computed tomography in patients with non-small cell lung cancer: normal variants and pitfalls J Comput Assist Tomogr 29 2 2005 205 209
78. G. Antoch, J. Stattaus, and A.T. Nemat Non-small cell lung cancer: dual-modality PET/CT in preoperative staging Radiology 229 2 2003 526 533
79. S.L. Aquino, J.C. Asmuth, N.M. Alpert, E.F. Halpern, and A.J. Fischman Improved radiologic staging of lung cancer with 2-[18F]-fluoro-2-deoxy-d- glucose-positron emission tomography and computed tomography registration J Comput Assist Tomogr 27 4 2003 479 484
80. R.J. Cerfolio, B. Ojha, A.S. Bryant, V. Raghuveer, J.M. Mountz, and A.A. Bartolucci The accuracy of integrated PET-CT compared with dedicated pet alone for the staging of patients with nonsmall cell lung cancer Ann Thorac Surg 78 3 2004 1017 1023 discussion 23
81. T.F. Hany, H.C. Steinert, G.W. Goerres, A. Buck, and G.K. von Schulthess PET diagnostic accuracy: improvement with in-line PET-CT system: initial results Radiology 225 2 2002 575 581
82. D. Lardinois, W. Weder, and T.F. Hany Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 25 2003 2500 2507
83. G.W. Goerres, E. Kamel, and B. Seifert Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system J Nucl Med 43 11 2002 1469 1475
84. G. Silvestri, B. Littenberg, and G. Colice The clinical evaluation for detecting metastatic lung cancer: a meta-analysis Am J Respir Crit Care Med 152 1995 225 230
85. G.A. Silvestri, L.T. Tanoue, M.L. Margolis, J. Barker, and F. Detterbeck The noninvasive staging of non-small cell lung cancer: the guidelines Chest 123 Suppl. 1 2003 147S 156S
86. G.W. Boland, M.J. Lee, G.S. Gazelle, E.F. Halpern, M.M. McNicholas, and P.R. Mueller Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature AJR Am J Roentgenol 171 1 1998 201 204
87. G.W. Boland, P.F. Hahn, C. Pena, and P.R. Mueller Adrenal masses: characterization with delayed contrast-enhanced CT Radiology 202 3 1997 693 696
88. C.S. Pena, G.W. Boland, P.F. Hahn, M.J. Lee, and P.R. Mueller Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT Radiology 217 3 2000 798 802
89. M. Yun, W. Kim, N. Alnafisi, L. Lacorte, S. Jang, and A. Alavi 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI J Nucl Med 42 12 2001 1795 1799
90. N.C. Gupta, G.M. Graeber, W.J. Tamim, J.S. Rogers, L. Irisari, and H.A. Bishop Clinical utility of PET-FDG imaging in differentiation of benign from malignant adrenal masses in lung cancer Clin Lung Cancer 3 1 2001 59 64
91. J.J. Erasmus, E.F. Patz Jr., and H.P. McAdams Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography AJR Am J Roentgenol 168 5 1997 1357 1360
92. K. Kagohashi, H. Satoh, H. Ishikawa, M. Ohtsuka, and K. Sekizawa Liver metastasis at the time of initial diagnosis of lung cancer Med Oncol 20 1 2003 25 28
93. D. Delbeke, W.H. Martin, M.P. Sandler, W.C. Chapman, J.K. Wright Jr., and C.W. Pinson Evaluation of benign vs malignant hepatic lesions with positron emission tomography Arch Surg 133 5 1998 510 515 discussion 5-6
94. A.G. Little, and F.P. Stitik Clinical staging of patients with non-small cell lung cancer Chest 97 6 1990 1431 1438
95. S.K. Cheran, J.E. Herndon 2nd, and E.F. Patz Jr. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer Lung Cancer 44 3 2004 317 325
96. I. Gayed, T. Vu, M. Johnson, H. Macapinlac, and D. Podoloff Comparison of bone and 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in the evaluation of bony metastases in lung cancer Mol Imaging Biol 5 1 2003 26 31
97. T.C. Hsia, Y.Y. Shen, R.F. Yen, C.H. Kao, and S.P. Changlai Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer Neoplasma 49 4 2002 267 271
98. P.C. Davis, P.A. Hudgins, and S.B. Peterman Diagnosis of cerebral metastases: double-dose delayed CT vs. contrast-enchanced MR imaging AJR 156 1991 1039 1046
99. B.J. Mintz, S. Turhim, and S. Alexander Intracranial metastases in the initial staging of bronchogenic carcinoma Chest 86 1984 850 853
100. J.F.H. Cole, J.E. Thomas, and A.B. Wilcox Cerebral imaging in the asymptomatic preoperative bronchogenic carcinoma patient: is it worthwhile? Ann Thorac Surg 57 1994 838 840
101. G. Colice, J. Birkmeyer, W. Black, B. Littenberg, and G. Silvestri Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases Chest 108 1995 1264 1271
102. D. Ferrigno, and G. Buccheri Cranial computed tomography as a part of the initial staging procedures for patients with non-small cell lung cancer Chest 106 1994 1025 1029
103. E.M. Rohren, J.M. Provenzale, D.P. Barboriak, and R.E. Coleman Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy Radiology 226 1 2003 181 187
104. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 3 2000 205 216
105. K.D. Hopper, C.J. Kasales, M.A. Van Slyke, T.A. Schwartz, T.R. TenHave, and J.A. Jozefiak Analysis of interobserver and intraobserver variability in CT tumor measurements AJR Am J Roentgenol 167 4 1996 851 854
106. J.J. Erasmus, G.W. Gladish, and L. Broemeling Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response J Clin Oncol 21 13 2003 2574 2582
107. American College of Radiology follow-up of non-small cell lung cancer: appropriateness criteria. Reston, VA: American College of Radiology; 1999.
108. National Comprehensive Cancer Network. Practice guidelines for non-small-cell lung cancer. Rockledge, PA: National Comprehensive Cancer Network; 2000.
109. Association of Community Cancer Centers. Oncology patient management guidelines, Version 3.0. Rockville, MD: Association of Community Cancer Centers; 2000.
110. G.L. Colice, J. Rubins, and M. Unger Follow-up and surveillance of the lung cancer patient following curative-intent therapy Chest 123 Suppl. 1 2003 272S 283S
111. T.J. Smith Evidence-based follow-up of lung cancer patients Semin Oncol 30 3 2003 361 368
112. G.L. Walsh, M. O'Connor, and K.M. Willis Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg 60 6 1995 1563 1570 discussion 70-2
113. V. Westeel, D. Choma, and F. Clement Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer Ann Thorac Surg 70 4 2000 1185 1190
114. F.G. Duhaylongsod, V.J. Lowe, E.F. Patz Jr., A.L. Vaughn, R.E. Coleman, and W.G. Wolfe Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography Ann Thorac Surg 60 5 1995 1348 1352
115. J.F. Vansteenkiste, S.G. Stroobants, and P.J. Dupont Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose- positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group J Clin Oncol 17 10 1999 3201 3206
116. S.K. Cheran, N.D. Nielsen, and E.F. Patz Jr. False-negative findings for primary lung tumors on FDG positron emission tomography: staging and prognostic implications AJR Am J Roentgenol 182 5 2004 1129 1132
117. E.F. Patz Jr., J. Connolly, and J. Herndon Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer AJR Am J Roentgenol 174 3 2000 769 774
118. W.A. Weber, V. Petersen, and B. Schmidt Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use J Clin Oncol 21 14 2003 2651 2657
119. W.A. Weber Use of PET for monitoring cancer therapy and for predicting outcome J Nucl Med 46 6 2005 983 995
120. H. Schoder, Y.E. Erdi, K. Chao, M. Gonen, S.M. Larson, and H.W. Yeung Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients J Nucl Med 45 4 2004 559 566
121. P. VanSchil The restaging issue Lung Cancer 42 Suppl 1 2003 S39 S45
122. J.F. Vansteenkiste, S.G. Stroobants, P.R. De Leyn, P.J. Dupont, and E.K. Verbeken Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group Ann Oncol 9 11 1998 1193 1198
123. J.L. Port, M.S. Kent, R.J. Korst, R. Keresztes, M.A. Levin, and N.K. Altorki Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer Ann Thorac Surg 77 1 2004 254 259
124. T. Akhurst, R.J. Downey, and M.S. Ginsberg An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer Ann Thorac Surg 73 1 2002 259 264 discussion 64-6
125. R.J. Cerfolio, B. Ojha, S. Mukherjee, A.H. Pask, C.S. Bass, and C.R. Katholi Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma J Thorac Cardiovasc Surg 125 4 2003 938 944